Financial Disclosure and conflict of interest. Upon Sponsor’s or Quintiles’ request, Institution agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to Quintiles a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub-investigators or their spouses or dependent children. Quintiles may withhold payments if it does not receive a completed form from each such investigator and sub-investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Institution agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, Quintiles, and their agents, and the Institution consents to such review. This Section 11 “Financial Disclosure and Conflict of Interest” shall survive termination or expiration of this Agreement.
Financial Disclosure and conflict of interest. Upon Sponsor’s or Quintiles’ request, Institution agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to Quintiles a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub- investigators or their spouses or dependent children. Quintiles may withhold payments if it does not receive a completed form from each such investigator and sub- investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Institution agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, Quintiles, and their agents, and the Institution consents to such review. Institution also acknowledges, that it did not enter into any contract that might interfere with the performance of the Study, or that might impair the acceptance of the resulting data by regulatory authorities, or create a conflict of interest. 12 Zamezení úplatkářství a podvodu Poskytovatel souhlasí, že jeho úsudek, pokud jde o poradenství a péči o každý subjekt hodnocení, nebude ovlivněn úhradou, kterou obdrží na základě této Smlouvy, a dále osvědčuje, že tato kompenzace nepřesahuje reálnou tržní hodnotu služeb, které poskytuje a že žádné platby nejsou poskytovány za účelem přimět Poskytovatele k nákupu nebo předepisování jakýchkoliv léků, zařízení nebo produktů. Pokud Zadavatel nebo Quintiles poskytnou jakékoli produkty nebo předměty pro použití ve Studii zdarma, Zdravotnické zařízení souhlasí, že nebude žádat úhradu po žádném Subjektu studie, pojišťovně nebo státním/správním úřadu nebo jakékoli jiné třetí straně za tyto zdarma poskytnuté produkty nebo předměty. Poskytovatel souhlasí, že nebude žádat úhradu po žádném Subjektu Studie, pojišťovně nebo státním úřadě za jakékoliv návštěvy, služby nebo výdaje vzniklé v průběhu Studie, za které obdrželo úhradu od Quintiles nebo Zadavatele, nebo které nejsou součástí běžné péče, kterou by za normálních okolností poskytlo Subjektu studie a že Poskytovatel nebude poskytovat platbu jinému lékaři za doporučení subjektů do Studie. Poskytovatel bere na vědomí, že pokud v době trvání této Smlouvy a dva (2) roky po jejím sk...
Financial Disclosure and conflict of interest. 12.1 Upon Study Sponsor’s or IQVIA’s request, Institution agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to Study Sponsor a financial and conflict of interest disclosure form provided by Study Sponsor or IQVIA that has been completed and signed by the Investigator or the applicable sub-investigator, which shall disclose any applicable interests held by Investigators or such sub-investigator or their respective spouses or dependent children. 12.1 Instituce souhlasí, že na základě žádosti Zadavatele klinického hodnocení nebo IQVIA Zkoušející lékař pro každého uvedeného a identifikovaného zkoušejícího lékaře nebo spoluzkoušejícího lékaře, kteří se přímo podílí na léčení nebo hodnocení Subjektů klinického hodnocení, neprodleně předá Zadavateli klinického hodnocení vyplněný a podepsaný formulář finančního prohlášení a konfliktu zájmů poskytnutý Zadavatelem klinického hodnocení nebo IQVIA, který byl vyplněn a podepsán Zkoušejícím lékařem nebo případným spoluzkoušejícím lékařem, ve kterém Zkoušející lékař či případný spoluzkoušející lékař přiznávají jakékoli příslušné zájmy, které xxxx oni xxxx xxxx jejich manželé/manželky či nezaopatřené děti. 12.2 IQVIA may withhold payments due under this Agreement if Study Sponsor does not receive a completed form from each of Investigator and any sub-investigator. 12.2 IQVIA je oprávněna pozdržet platby podle této Smlouvy v případě, že Zadavatel klinického hodnocení neobdrží vyplněné formuláře od Zkoušejícího lékaře a případného spoluzkoušejícího lékaře. 12.3 Zkoušející lékaře zajistí urychlenou aktualizaci formulářů dle potřeby, s cílem zajistit jejich přesnost a úplnost v průběhu realizace Klinického hodnocení a po
Financial Disclosure and conflict of interest. Upon Sponsor’s or IQVIA’s request, Site agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to IQVIA a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub-investigators or their spouses or dependent children. IQVIA may withhold payments if it does not receive a completed form from each such investigator and sub-investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Site agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, IQVIA, and their agents, and the Site consents to such review. klinického hodnocení se dále zavazuje neprodleně vyrozumět IQVIA v případě, že dojde k takovému vyšetřování, diskvalifikaci, uložení sankce zákazu výkonu činnosti nebo k odejmutí oprávnění k výkonu klinického hodnocení. Tento Článek 10 „Vyloučení“ zůstane v platnosti po ukončení nebo uplynutí doby trvání této Smlouvy.
Financial Disclosure and conflict of interest. NSABP shall collect financial disclosure statements from each Investigator sufficient to allow Antigen Express to submit complete and accurate certification or disclosure statements required under 21 CFR Part 54. In the event Antigen Express decides to file the results and Antigen Express Study Data with the FDA and/or another health authority in support of a marketing authorization, NSABP will reasonably assist Antigen Express in meeting its certification and disclosure obligations including, without limitation, by providing Antigen Express with the financial disclosure statements and assisting Antigen Express in collecting any missing information from Investigators.
Financial Disclosure and conflict of interest. I affirm that I have no financial affiliation (including research funding) or involvement with any commercial organization that has a direct financial interest in any matter included in this manuscript, except as disclosed in an attachment and cited in the manuscript. Any other conflict of interest (ie, personal associations or involvement as a director, officer, or expert witness) is also disclosed in an attachment.
Financial Disclosure and conflict of interest. Upon Sponsor’s or Quintiles’ request, Site agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to Quintiles a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub-investigators or their spouses or dependent children. Quintiles may withhold payments if it does not receive a completed form from each such investigator and sub-investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Site agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, Quintiles, and their agents, and the Site consents to such review. The Investigator further consents to the transfer of his/her financial disclosure data to the Sponsor’s country of origin and to the U.S., even though data protection may not exist or be as developed in those countries as in the Site’s own country. This Section 11 “Financial Disclosure and Conflict of Interest” shall survive termination or expiration of this Agreement.
Financial Disclosure and conflict of interest. Upon Sponsor’s or IQVIA’ request, Site agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to IQVIA a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub-investigators or their spouses or dependent children. IQVIA may withhold payments if it does not receive a completed form from each such investigator and sub-investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Site agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, IQVIA, and their agents, and Clinical Trial Agreement/ Smlouva o klinickém hodnocení Esperion Therapeutics, Inc./ 1002-043 Fakultní nemocnice Hradec Králové/ Tento Článek 10 „Vyloučení“ zůstane v platnosti po ukončení nebo uplynutí doby trvání této Smlouvy.
Financial Disclosure and conflict of interest. Institution agrees that Investigator and sub- investigators provide Financial Disclosure Forms.
Financial Disclosure and conflict of interest. Upon Sponsor’s or IQVIA’s request, Site agrees that, for each listed or identified investigator or sub-investigator who is directly involved in the treatment or evaluation of Study Subjects, Investigator shall promptly return to IQVIA a financial and conflict of interest disclosure form that has been completed and signed by such investigator or sub-investigator, which shall disclose any applicable interests held by those investigators or sub-investigators or their spouses or dependent children. IQVIA may withhold payments if it does not receive a completed form from each such investigator and sub-investigator. Investigator shall ensure that all such forms are promptly updated as needed to maintain their accuracy and completeness during the Study and for one (1) year after Study completion. Site agrees that the completed forms may be subject to review by governmental or regulatory agencies, Sponsor, IQVIA, and their agents, and the Site consents to such review. The Investigator further consents to the transfer of his/her financial disclosure data to the Sponsor’s country of origin and to the U. S., even though data protection may not exist or be as developed in those countries as in the Site’s own country.
